Skip to content

SUENOVIDA

Active
Private limited companyfounded 2012active for 14 yearsIJzerstraat 3, 8370 Blankenberge, BelgiumKBO/BCE: BE 0849.946.563
Summary

SUENOVIDA has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €36,728 and a net result of €3,285. Equity has been growing by about 9.9% per year since 2018. Its solvency ranks better than 31% of 825 sector peers (NACE 58, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 16-10-2012 Normal situation
Activity
Book publishing NACE 58110and 4 others
Establishment unit
2.213.831.889 8370 Blankenberge, since 08-11-2012
Financial year end
31 December
Peppol
Reachable since 10-12-2025

Board and ownership

Board
  • Niclaus MichaëlDirector

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€42,699
▼ 31.4%
Turnover
≈ €170,000
estimated
Profit
€3,285
▼ 84.8%
Equity
€36,728
▲ 9.8%
Total assets
€199,664
▲ 1.5%
Employees on 31-12-2025
1
=
Score breakdownraises riskEquity €36,728 (18.4% of total assets)lowers riskSector: Publishing activities (NACE 58)Liquidity: current ratio 1.34, cash €53,203Size: total assets €199,664Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 52% of micro companies in publishing (NACE 58)
Financial strength · tick: 2024
Strong
Solvency 43+1
equity 18.4% of total assets
Liquidity 75+13
short-term debt 23.8% · cash 26.6%
Profitability 71-11
return on assets 1.6%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (1,282 companies, NACE 58, micro)
Last 24 months 12-2024: 1.0%highest value 01-2025: 1.0%● unchanged vs 12-2024 02-2025: 1.0%● unchanged vs 01-2025 03-2025: 1.0%● unchanged vs 02-2025 04-2025: 0.9%▼ -0.1 percentage points vs 03-2025 05-2025: 0.9%● unchanged vs 04-2025 06-2025: 0.9%● unchanged vs 05-2025 07-2025: 0.1%▼ -0.8 percentage points vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026lowest value 08-2026: 0.1%● unchanged vs 07-2026lowest value 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026
Credit of up to €3,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.34 (0.98 in 2024), below the usual 1.5. Short-term debt is 23.8% and cash 26.6% of total assets. 81.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 58, micro). It does better than 31% of them on solvency, 66% on liquidity, 50% on profitability and 62% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Publishing activities (NACE 58)
KBO
lowers risk · Liquidity: current ratio 1.34, cash €53,203
NBB · annual accounts
lowers risk · Size: total assets €199,664
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Equity €36,728 (18.4% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 04-06-2026, 57 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
57 days early
2024
59 days early
2023
58 days early
2022
31 days late
2021
6 days early
2020
33 days early
2019
30 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 30 days before the deadline. In the sector (NACE 58), the median for financial year 2024 was 7 days before the deadline, and 37% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 4 June (4 of the last 5 accounts filed within 51 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Recent changes

  1. · Gazette deed Amendment of the articles · Legal-form change · Resignations & appointments
  2. · Gazette deed Registered office moved from Heusden to BlankenbergeNew seat: IJzerstraat 3 te 8370 Blankenberge · Previous seat: TER HAM 3, 9070 HEUSDEN
  3. · Gazette deed Incorporation
All 17 events

Comparable companies

These companies have the same main activity as SUENOVIDA: book publishing (NACE 58110). They are comparable in size and age: total assets between €164,000 and €349,000, founded between 2008 and 2015.

CompanyTotal assetsGross margin
SUENOVIDA Blankenberge€199,664€42,699
Maja Publishing Roeselare€163,935€18,130
Elysway Menen€348,644€57,768
APPETIZING Essen€265,765€66,343
THENEWPUB Anderlecht€166,427€63,186
THE RIGHT PEOPLE Gent€170,171€59,773
INDELEBILIS Oudergem€223,585€30,527
Full comparison

Key facts about SUENOVIDA

What is the company number of SUENOVIDA?
The company number of SUENOVIDA is 0849.946.563. The VAT number is the same number with BE in front: BE 0849.946.563.
Where is SUENOVIDA based?
The registered office is at IJzerstraat 3, 8370 Blankenberge.Company details
What does SUENOVIDA do?
According to the KBO register, the main activity is book publishing (NACE 58110).
What is the legal form of SUENOVIDA?
The legal form of SUENOVIDA is Private limited company (BV).
When was SUENOVIDA founded?
SUENOVIDA was founded on 16-10-2012.
Is SUENOVIDA still active?
Yes, SUENOVIDA is an active enterprise in the KBO register.
How many employees does SUENOVIDA have?
SUENOVIDA had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of SUENOVIDA?
The turnover in financial year 2025 is ≈ €170,000. This figure is estimated from the gross margin of €42,699 and 2,953 comparable companies of the same size. It probably lies between €100,000 and €310,000. It is a rough estimate.
Is SUENOVIDA profitable?
In financial year 2025, SUENOVIDA made a profit of €3,285.
Where can I find the annual accounts of SUENOVIDA?
SUENOVIDA filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of SUENOVIDA due?
SUENOVIDA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.